Vaccines, blood, antisera, toxins and cultures in   Norway

Exports In 2023, Norway exported $98.1M in Vaccines, blood, antisera, toxins and cultures, making it the 39th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 108th most exported product in Norway. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Norway are: Chile ($53.9M), United Kingdom ($10.5M), Austria ($5.98M), Denmark ($5.33M), and Turkey ($4.29M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Norway between 2022 and 2023 were United Kingdom ($4.23M), Chile ($3.72M), and Austria ($1.39M).

Imports In 2023, Norway imported $674M in Vaccines, blood, antisera, toxins and cultures, becoming the 39th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 25th most imported product in Norway. Norway imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($178M), Switzerland ($95.3M), United States ($77.2M), Canada ($67.1M), and Ireland ($46.8M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Norway between 2022 and 2023 were Switzerland ($11.1M), Canada ($10M), and Denmark ($2.78M).